Table III. Major studies on results of hepatectomy for NCRNNE liver metastases.
First author | Year | n | Median age | UPT | NE | Major resection | Perioperative mortality% | R0 | Overall 5-year survival% |
---|---|---|---|---|---|---|---|---|---|
Elias 10 | 1998 | 147 | 56 | 3 | 18% | – | 2 | 75% | 36 |
Hemming 4 | 2000 | 37 | 56 | 3 | – | 62% | 0 | 89% | 45 |
Benevento 5 | 2000 | 18 | 54 | – | 22% | 17% | 0 | – | 21 |
Laurent 7 | 2001 | 39 | 55 | – | – | 51% | 0 | – | 35 |
Yedibela 8 | 2005 | 162 | 60 | 10 | 9% | 38% | 1 | 72% | 26 |
Ercolani 14 | 2005 | 83 | 54 | – | – | 41% | 0 | – | 34 |
Cordera 11 | 2005 | 64 | 56 | 3 | – | 59% | 1.5 | 88% | 30 |
Weitz 12 | 2005 | 141 | 55 | 5 | – | 48% | 0 | 96% | 57 (3-year) |
Adam 3 | 2006 | 1452 | 53 | 29 | – | 55% | 2.3 | 83% | 36 |
Earle 20 | 2006 | 95 | 58 | – | 19% | 41% | 2.1 | 88% | 35 |
Reddy 2 | 2006 | 82 | 52 | 2 | 9% | 52% | 4 | 79% | 37 |
Lendoire | 2007 | 106 | 54 | – | – | 48% | 1.8 | 90% | 19 |
UPT = number of patients with unknown primary tumors; NE = number of patients with neuroendocrine tumors.